Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Genfit delays high-stakes PhIII NASH readout; Bristol-Myers grabs first Opdivo OK in esophageal cancer
6 years ago
News Briefing
Gilead loses two more patent challenges on HIV pill, setting up courtroom fight in Delaware
6 years ago
R&D
Bankrupt antibiotics maker Aradigm turns to old partner/investor for final $3M fire sale
6 years ago
Deals
DBV's peanut prevention patch approaches key stage of approval process
6 years ago
R&D
Antonio Gualberto starts post-Kura career at Eisai subsidiary H3; eFFECTOR co-founder Siegfried Reich jumps to ...
6 years ago
Peer Review
Say goodbye to Tocagen, struggling brain cancer biotech to reverse merge with Forte Biosciences
6 years ago
Deals
Speedy review and no adcomm for BioMarin's pioneering hemophilia gene therapy
6 years ago
Cell/Gene Tx
FDA+
Gene therapy pioneer Kathy High has left Spark after completing $4.3B union with Roche
6 years ago
People
Cell/Gene Tx
Pharmacogenetics: FDA releases table of gene-drug interactions
6 years ago
Pharma
FDA+
Heron's Groundhog Day; Vifor forms JV with Fresenius Kabi in China
6 years ago
News Briefing
Fresh off $100M round, GV-backed real-world data startup woos Duke researcher as CMO
6 years ago
People
Startups
Merck loses its chief digital officer, spotlighting talent hunt for the hottest title in Big Pharma
6 years ago
People
R&D
Don't let AbbVie fool FTC with an easy divestiture, plead critics in latest attack on $63B Allergan buyout
6 years ago
Deals
Pharma
Austedo, Teva's bright spot as it executes turnaround, fails two Tourette's trials
6 years ago
Pharma
Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic
6 years ago
R&D
FDA consolidates nonclinical immunotoxicity evaluation guidance
6 years ago
FDA+
Eli Lilly vet Kerry Blanchard takes the helm at one of China's top dealmakers, steering toward first approvals
6 years ago
People
China
TCR-focused Immatics adds another marquee name to its list of partners: GSK
6 years ago
Deals
Cell/Gene Tx
Incyte's topical Jakafi scores again in eczema Phase III; Priority review lines Roche's Tecentriq up for new lung ...
6 years ago
News Briefing
DuPont makes another foray into drug R&D, throwing its name into the microbiome hat
6 years ago
Deals
For two decades, a new vaccine technology has been slowly approaching prime time. Now, can it stop a pandemic?
6 years ago
R&D
In Focus
Cellectis boosts its coffers in revised off-the-shelf CAR-T deal with Servier
6 years ago
R&D
Bristol-Myers shrugs off another Opdivo combo flop as $1.74B deal goes pfffft
6 years ago
R&D
Biotech CEO who lied about curing his own paralysis sentenced to 7 years in jail
6 years ago
People
First page
Previous page
853
854
855
856
857
858
859
Next page
Last page